Ironwood Pharmaceuticals, Inc. - Class A IRWD
$4.25
+2.91%
at last close
Financials (TTM)
- Revenue
- $389.32 million
- Net Income
- $129.87 million
- Net Margin
- 33.36%
- Return on Equity
- -80.24%
- Debt-to-Equity
- —
- P/E Ratio
- 5.52
- Price / Book
- -4.22
- Price / Sales
- 1.75
Over the trailing twelve months, Ironwood Pharmaceuticals, Inc. - Class A generated revenue of $389.32 million and net income of $129.87 million, a net margin of 33.36%.
At the last closing price of $4.25, IRWD trades at 5.52 times trailing earnings and 1.75 times sales, with a market capitalization of $682.44 million.
Key Stats
- Last Close
- $4.25
- Market Cap
- $682.44 million
- 52-Week Range
- $0.71 – $5.78
- Average Volume
- 1.97 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.